The Effects of Rapid Rewarming on Tissue Salvage in Severe Frostbite Injury.


Journal

Journal of burn care & research : official publication of the American Burn Association
ISSN: 1559-0488
Titre abrégé: J Burn Care Res
Pays: England
ID NLM: 101262774

Informations de publication

Date de publication:
01 07 2022
Historique:
pubmed: 19 11 2021
medline: 8 7 2022
entrez: 18 11 2021
Statut: ppublish

Résumé

Frostbite is a high morbidity injury caused by soft tissue freezing, which can lead to digit necrosis requiring amputation. Rapid rewarming is a first-line treatment method that involves placing affected digits into a warm water bath. This study aims to assess the clinical practices for frostbite at facilities outside of dedicated burn centers, and any impact these practices have on tissue salvage. Retrospective chart review at a single burn center identified frostbite patients admitted directly or as transfers over a 7-year period. Records were reviewed to identify initial treatment strategies. If given, time to thrombolytics from admit was noted. Tissue salvage rates were calculated from radiologically derived tissue at-risk scores and final amputation scores. One-hundred patients were transferred from outside facilities, and 108 were direct admissions (N = 208). There was no significant difference in group demographics. Rapid rewarming was the initial treatment modality more commonly in direct admit patients (P = .016). The use of rapid rewarming did not correlate with tissue salvage (P = .112). Early use of thrombolytics had a positive impact on tissue salvage (P = .003). Thrombolytics were given 1.2 hours earlier in direct admit patients (P = .029), however there was no difference in tissue salvage rates between the groups (P = .127). Efforts should focus on larger scale study to further assess the effectiveness of rapid rewarming. Although rapid rewarming did not significantly impact tissue salvage in this study, we continue to recommend its use over less studied treatment methods, and continue to view it as an important bridge to burn center transfer and administration of thrombolytic therapy.

Identifiants

pubmed: 34791315
pii: 6429712
doi: 10.1093/jbcr/irab218
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

906-911

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the American Burn Association. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Charlotte Rogers (C)

Hennepin Healthcare, Minneapolis, MN, USA.

Alexandra M Lacey (AM)

Hennepin Healthcare, Minneapolis, MN, USA.

Frederick W Endorf (FW)

Hennepin Healthcare, Minneapolis, MN, USA.

Gopal Punjabi (G)

Hennepin Healthcare, Minneapolis, MN, USA.

Angela Whitley (A)

Hennepin Healthcare, Minneapolis, MN, USA.

Jon Gayken (J)

Hennepin Healthcare, Minneapolis, MN, USA.

Ryan Fey (R)

Hennepin Healthcare, Minneapolis, MN, USA.

Kyle Schmitz (K)

Hennepin Healthcare, Minneapolis, MN, USA.

Rachel M Nygaard (RM)

Hennepin Healthcare, Minneapolis, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH